Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors

Area of Science:

• Oncology
• Cancer Metabolism
• Mitochondrial Biology

Background:

• Tumor microenvironments are often nutrient-poor, hypoxic, and acidic due to disorganized vasculature.
• Slowly proliferating tumor cells in these areas are resistant to conventional chemotherapy.
• There is a critical need for novel therapeutic strategies that do not depend on cell cycle activity.

Purpose of the Study:

• To identify therapeutic targets for quiescent tumor cells.
• To explore alternative treatment strategies circumventing growth dependency.
• To investigate the role of mitochondria in the survival of tumor cells in adverse microenvironments.

Main Methods:

• Screening of drug libraries using multicellular tumor spheroids (MCTS).
• Utilizing glucose-starved tumor cells as a model system.
• Analyzing compounds identified for their effects on mitochondrial function.

Main Results:

• Drug screens identified compounds active against quiescent tumor cells.
• A common characteristic of effective compounds was their impact on mitochondrial function.
• Contrary to the Warburg effect, tumor cells in nutrient-deprived conditions depend on mitochondria for energy and survival.

Conclusions:

• Mitochondria are crucial for the survival of slowly proliferating tumor cells.
• Targeting mitochondrial function represents a promising therapeutic strategy for resistant cancer populations.
• These findings challenge the classical Warburg hypothesis in specific tumor microenvironments.